You can't have it both ways. You can't accuse the company of intentionally delaying the Def for motives of pumping and tricking investors, while at the same time acknowledge that the SEC is at least partly responsible for the delays in requesting modifications to the Pre's.
The Pre's don't even do anything for the PPS, and that's been obvious for a while. So why would they intentionally delay the dividend in order to pump Pre's and PR's that have no effect?
You see, until a few weeks ago, I also thought that they could be intentionally delaying the dividend and flooding us with Pre's for other motives. But in light of the evidence, it seems pretty clear that they are involved in a modification process with the SEC. So the answer and the guilt lies somewhere in the middle, imo.
As for the cancer PR, there's not much excuse for that. Bob said he likes to use CBIS to get the word out about cannabis.